Germany & France Propose Reforms To Give The WHO More Power, Funding & Oversight 20/08/2020 Editorial team Germany and France are proposing sweeping reforms to strengthen the World Health Organization and ramp up funding for the agency. A draft paper circulated by the two countries outlines ten key reforms to boost the WHO’s legal authority and funding, while also increasing oversight of the agency’s emergency operations, according to Reuters, which obtained a […] Continue reading -> Health Experts Criticize Decision To Replace Public Health England During Pandemic 19/08/2020 Grace Ren United Kingdom Secretary of State for Health Matt Hancock’s announcement to replace Public Health England (PHE) with a new agency focused on biosecurity and infectious disease threats has drawn widespread criticism from health experts. The Health Secretary announced that PHE will be replaced with a new National Institute for Health Protection (NIHP) in a speech […] Continue reading -> COVID-19: The Sky Hasn’t Fallen Yet In Africa 15/08/2020 Paul Adepoju This week, the Africa Center for Disease Control (Africa CDC) will be launching a continent-wide antibody study to measure the true extent of the COVID-19 pandemic in Africa, where reported coronavirus cases are much lower than initial dire predictions. Africa CDC Director John Nkengasong announced the study at a regular Thursday press briefing. Just a […] Continue reading -> Patchwork Of Traveler Testing & Quarantine Policies Cause Confusion; WHO Says Travelers Should Be Prepared For Sudden Changes 07/08/2020 Grace Ren A World Health Organization spokesperson on Friday said that the Organization is not well-positioned to make specific recommendations about when, where, and how travelers should be tested or quarantined for COVID-19 as countries reopen aviation, deferring the policy question to national governments. “Some of it is really dependent on what your national authorities ask of […] Continue reading -> Indian Clean Air Advocates Slam Supreme Court Order Pushing Questionable “Smog Tower” Technology 05/08/2020 Jyoti Pande Lavakare Environmentalists and scientists have called out the recent Indian Supreme Court decision directing the government to install “smog towers” in Delhi as an injudicious move that will lead to a waste of public money. The opposition escalated after the Court on Tuesday, ordered the government to begin installing the smog towers within the next week. […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Health Experts Criticize Decision To Replace Public Health England During Pandemic 19/08/2020 Grace Ren United Kingdom Secretary of State for Health Matt Hancock’s announcement to replace Public Health England (PHE) with a new agency focused on biosecurity and infectious disease threats has drawn widespread criticism from health experts. The Health Secretary announced that PHE will be replaced with a new National Institute for Health Protection (NIHP) in a speech […] Continue reading -> COVID-19: The Sky Hasn’t Fallen Yet In Africa 15/08/2020 Paul Adepoju This week, the Africa Center for Disease Control (Africa CDC) will be launching a continent-wide antibody study to measure the true extent of the COVID-19 pandemic in Africa, where reported coronavirus cases are much lower than initial dire predictions. Africa CDC Director John Nkengasong announced the study at a regular Thursday press briefing. Just a […] Continue reading -> Patchwork Of Traveler Testing & Quarantine Policies Cause Confusion; WHO Says Travelers Should Be Prepared For Sudden Changes 07/08/2020 Grace Ren A World Health Organization spokesperson on Friday said that the Organization is not well-positioned to make specific recommendations about when, where, and how travelers should be tested or quarantined for COVID-19 as countries reopen aviation, deferring the policy question to national governments. “Some of it is really dependent on what your national authorities ask of […] Continue reading -> Indian Clean Air Advocates Slam Supreme Court Order Pushing Questionable “Smog Tower” Technology 05/08/2020 Jyoti Pande Lavakare Environmentalists and scientists have called out the recent Indian Supreme Court decision directing the government to install “smog towers” in Delhi as an injudicious move that will lead to a waste of public money. The opposition escalated after the Court on Tuesday, ordered the government to begin installing the smog towers within the next week. […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19: The Sky Hasn’t Fallen Yet In Africa 15/08/2020 Paul Adepoju This week, the Africa Center for Disease Control (Africa CDC) will be launching a continent-wide antibody study to measure the true extent of the COVID-19 pandemic in Africa, where reported coronavirus cases are much lower than initial dire predictions. Africa CDC Director John Nkengasong announced the study at a regular Thursday press briefing. Just a […] Continue reading -> Patchwork Of Traveler Testing & Quarantine Policies Cause Confusion; WHO Says Travelers Should Be Prepared For Sudden Changes 07/08/2020 Grace Ren A World Health Organization spokesperson on Friday said that the Organization is not well-positioned to make specific recommendations about when, where, and how travelers should be tested or quarantined for COVID-19 as countries reopen aviation, deferring the policy question to national governments. “Some of it is really dependent on what your national authorities ask of […] Continue reading -> Indian Clean Air Advocates Slam Supreme Court Order Pushing Questionable “Smog Tower” Technology 05/08/2020 Jyoti Pande Lavakare Environmentalists and scientists have called out the recent Indian Supreme Court decision directing the government to install “smog towers” in Delhi as an injudicious move that will lead to a waste of public money. The opposition escalated after the Court on Tuesday, ordered the government to begin installing the smog towers within the next week. […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Patchwork Of Traveler Testing & Quarantine Policies Cause Confusion; WHO Says Travelers Should Be Prepared For Sudden Changes 07/08/2020 Grace Ren A World Health Organization spokesperson on Friday said that the Organization is not well-positioned to make specific recommendations about when, where, and how travelers should be tested or quarantined for COVID-19 as countries reopen aviation, deferring the policy question to national governments. “Some of it is really dependent on what your national authorities ask of […] Continue reading -> Indian Clean Air Advocates Slam Supreme Court Order Pushing Questionable “Smog Tower” Technology 05/08/2020 Jyoti Pande Lavakare Environmentalists and scientists have called out the recent Indian Supreme Court decision directing the government to install “smog towers” in Delhi as an injudicious move that will lead to a waste of public money. The opposition escalated after the Court on Tuesday, ordered the government to begin installing the smog towers within the next week. […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Indian Clean Air Advocates Slam Supreme Court Order Pushing Questionable “Smog Tower” Technology 05/08/2020 Jyoti Pande Lavakare Environmentalists and scientists have called out the recent Indian Supreme Court decision directing the government to install “smog towers” in Delhi as an injudicious move that will lead to a waste of public money. The opposition escalated after the Court on Tuesday, ordered the government to begin installing the smog towers within the next week. […] Continue reading -> EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EU Orphan Drug Regulations Haven’t “Failed” But Reforms Needed, Says CEO Of European Rare Disease NGO 04/08/2020 Svĕt Lustig Vijay European legislation on drugs for rare diseases is “far from perfect”, but it is not a ‘failure’ given the amount of private sector investment it has attracted in the past two decades, says Yann Le Cam, CEO of EURORDIS – Rare Diseases Europe, a non-profit alliance of some 930 rare disease patient organisations across 72 […] Continue reading -> More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
More “Skin In The Game” Needed To Defeat Tuberculosis 03/08/2020 Grace Ren Amidst the battle against a new infectious threat, the fight against tuberculosis, one of humankind’s oldest recorded infectious diseases, is also progressing. Pretomanid – only the second TB drug to hit the market in over two decades – received conditional marketing approval Monday from the European Commission as part of a new, three-drug treatment regimen […] Continue reading -> Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Formula 1 Still Benefiting From Tobacco Sponsorships, Despite Public Promise To Cut Ties With The Industry 31/07/2020 Grace Ren The racing sport Formula 1 (F1) has made more than US $4.4 billion in advertising and sponsorship from tobacco companies in the past seven decades, according to a report published by F1 industry monitor Formula Money and global tobacco industry watchdog STOP. The first-ever analysis of its kind, Driving Addiction: F1 and Tobacco Advertising, was published just […] Continue reading -> South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa’s COVID-19 Cases Explode As Country Tries To Rescue Its Economy 31/07/2020 Kerry Cullinan Four months after South Africa implemented one of the strictest lockdowns in the world, it appears that neither lives nor livelihoods have been spared. South African President Cyril Ramaphosa was widely praised for taking decisive action when he introduced one of the fastest and strictest lockdowns in the world in late March. Within three weeks […] Continue reading -> Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group 30/07/2020 Svĕt Lustig Vijay Big pharma has reaped billions in profit off the back of European orphan drug regulations that are supposed to incentivize R&D for rare diseases, according to an analysis of 120 orphan medicines registered in the EU over the past two decades. Instead of incentivizing R&D for rare maladies, the EU’s orphan drug legislation has turned […] Continue reading -> Posts navigation Older postsNewer posts